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Abstract Discoveries from the Human Genome Project
have invigorated discussions of epigenetic effects—modi-
fiable chemical processes that influence DNA’s ability to
give instructions to turn gene expression on or off—on
health outcomes. We suggest three domains in which new
understandings of epigenetics could inform innovations in
health promotion research: (1) increase the motivational
potency of health communications (e.g., explaining indi-
vidual differences in health outcomes to interrupt opti-
mistic biases about health exposures); (2) illuminate new
approaches to targeted and tailored health promotion
interventions (e.g., relapse prevention targeted to epige-
netic responses to intervention participation); and (3)
inform more sensitive measures of intervention impact,
(e.g., replace or augment self-reported adherence). We
suggest a three-step process for using epigenetics in health
promotion research that emphasizes integrating epigenetic
mechanisms into conceptual model development that then
informs selection of intervention approaches and outcomes.
Lastly, we pose examples of relevant scientific questions
worth exploring.
Keywords Health promotion  Epigenetics 
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Introduction
Over the last two decades, discoveries from the Human
Genome Project (HGP) and visions for applying genomics
in everyday medical care (aka precision medicine) have
invigorated discussions of epigenetics (Collins & Varmus,
2015). Findings that humans have considerably fewer
genes than anticipated have supported notions that bio-
logical processes in addition to the genome—epigenetic
mechanisms—must be influencing gene expression and
observed variation in traits and health outcomes (Claverie,
2005). Further, there is evidence that the majority of
common genetic variants (i.e., single nucleotide polymor-
phisms or SNPs) are of low penetrance and do not directly
result in observable traits (Wild, 2005). Indeed, most of
these variants appear to influence disease risk only in the
presence of an environmental exposure that prompts epi-
genetic mechanisms and gene expression (Wild, 2005).
Such emerging understandings likely will position epige-
netics front and center in future discussions of genomics
and health promotion research.
In this report, we consider where these new under-
standings have the potential to add value and foster inno-
vation in the development and evaluation of health
promotion interventions. We suggest three domains in
which epigenetic mechanisms could inform such innova-
tions: (1) updates in health risk information that could
improve the motivational potency of health communica-
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tions (e.g., explaining individual differences in health
outcomes to interrupt optimistic biases about risk expo-
sures); (2) illuminate new approaches to targeted and tai-
lored interventions (e.g., relapse prevention targeted to
epigenetic response to intervention participation); and (3)
inform more sensitive measures of intervention impact
(e.g., replace or augment self-reported adherence). Addi-
tionally, we discuss feasible ways to use epigenetics in
health promotion interventions and related research meth-
ods, and provide practical ‘‘how to’’ steps for getting there.
But, first, we go under the hood with a technical overview
of epigenetic concepts that could inform these innovations.
Technical overview of epigenetics
Epigenetic mechanisms are the chemical processes that
influence the ability of deoxyribonucleic acid (DNA) to
give instructions (i.e., whether and how genes are expres-
sed) and influence whether phenotypes associated with
gene variants become manifest physically or clinically
(Feinberg, 2013). Environmental exposures are thought to
prompt these chemical processes. Consider, for example,
research showing that monozygotic twins who are geneti-
cally identical at birth develop different physical charac-
teristics as they age (Fraga et al., 2005). These differences
are thought to arise from the accumulation of epigenetic
responses to increasingly divergent environmental expo-
sures that twins experience as they spend less of their lives
together (Fraga et al., 2005). Thus, epigenetic processes are
suggested to explain how environmental exposures impact
health across the lifespan.
Epigenetic processes
Epigenetic mechanisms are now understood to play a
critical role in regulation of gene expression, allowing
different cells to express different portions of the genome
(Herceg et al., 2013). The processes governing gene
expression are rooted in how DNA is stored. DNA strands,
too long to fit neatly into the nucleus of cells, are wrapped
in a dynamic and functional structure called chromatin.
DNA is then wound around three dimensional protein
structures called ‘‘histones’’ or spools of different types that
offer specific storage services and perform somewhat dif-
ferent mechanical functions to manage cell processes
(Lawrence et al., 2016). These histones have ‘‘tails’’ that
act as receiving stations for a variety of modifications made
to the genome that influence gene expression and function.
The best understood of these chemical reactions is
methylation, a biochemical process in which a methyl
group (i.e., a chemical compound) gets added to the histone
tail (Bakulski & Fallin, 2014; Bjornsson et al., 2004;
Feinberg, 2013). This methylation, in part, modifies the
histone by strengthening the charge (i.e., the magnetic
hold) of the spool such that the DNA is packed more tightly
around the spool. This tight packing makes the DNA less
accessible and restricts DNA from being read (i.e. tran-
scribed), essentially ‘‘turning off’’ gene expression. Alter-
natively, demethylation neutralizes the charge of the
histone spool, loosening the tension and allowing the DNA
to be read more easily, essentially ‘‘turning on’’ gene
expression. It is noteworthy that most genes in humans are
methylated or ‘‘turned off’’. Thus, exposures in the envi-
ronment often function by turning on gene expression (i.e.,
demethylation) and prompting pathological processes such
as cell proliferation, a process that characterizes many
cancers (Feinberg, 2013; Herceg et al., 2013). Most
important for health promotion interventions is that
demethylation can be reversed, offering an opportunity to
reverse the negative impact of environmental exposures
(Godfrey et al., 2007).
Methylation processes tend to occur in ‘‘CpG Islands’’ that
is at locations in the genome where there are long repeated
sequences of bases of a cytosine nucleotide or ‘‘C’’ located
next to a guanine nucleotide or ‘‘G’’; each of these C–G pairs
are separated by one phosphate, hence the CpG denotation. In
turn, CpG islands tend to be near sites of human gene ‘‘pro-
moters’’ (How Kit et al., 2012). These regions of the gene are
typically not methylated, comprise looser bonds that increase
their ability to be read, and are thought to be especially
important in regulating gene expression.
As described above these epigenetic mechanisms are
thought to be influenced by exposures that span from micro
‘‘in vivo’’ exposures to macro-level social influences.
Indeed, Wild refers to this as the ‘‘exposome’’ that includes
every exposure to which an individual has been subjected
from conception to death (Wild, 2005).
Conceptualizing the exposome
Early conceptualizations of epigenetics emphasized the
toxicological role of exposures in damaging DNA (e.g.,
tobacco exposure), which in turn contributed to cancer and
other disease etiology (Wild et al., 2013). Such conceptu-
alizations have been broadened over time to give attention
to social, behavioral and psychological factors that can
influence epigenetic mechanisms and gene expression
(Myers, 2009). These include but are not limited to social
capital, education, financial status, health behaviors, and
psychological stress. Additionally, these exposures can
include social structural and cultural experiences that
come, for example, from living in rural versus urban
environments and the contexts of differing social norms
(Gehlert et al., 2008; Juarez et al., 2014; Thayer &
Kuzawa, 2011). More recently the built environment, a key
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factor implicated in health disparities, has been added as
part of this ‘‘public health exposome’’ (Juarez et al., 2014).
Integrating epigenetics into health promotion interven-
tions aligns well with the field’s growing emphasis on
socio-ecological frameworks in which multiple levels of
social and behavioral influences on health are considered as
a set of ‘‘nested complexities’’ (Glass & McAtee, 2006).
Epigenetics could aid in characterizing how these influ-
ences or exposures become embodied via their influence on
gene expression (Essex et al., 2013; Krieger, 1999).
It is well known that epigenetic alterations accumulate
with age (Sierra et al., 2015). However, understandings of
epigenetic mechanisms also indicate that the timing and
chronicity of exposure is very important. Thus, considering
epigenetic mechanisms reifies suggestions that health pro-
motion research take a lifespan approach (Uchino, 2009). For
epigenetics, environmental responsivity is especially
heightened at some periods of human development including
perinatal, peri-pubertal, and for women, during the meno-
pausal transition (Kanherkar et al., 2014). Some have sug-
Fig. 1 Conceptualizing the
exposome and epigenetic
processes. The blue strands of
DNA are wrapped in a dynamic
and functional structure called
chromatin. As illustrated in the
figure, the DNA is wound
around histones. Histone tails
receive modifications, or
epigenetic marks, that turn on or
turn off gene expression. One
such modification is
methylation, in which a methyl
group, represented by the blue
pentagon, attaches to the
histone tail. DNA is wrapped
more tightly around histones
that are highly methylated,
restricting accessibility of the
DNA to be read for gene
expression. Methylation of
DNA occurs in areas of density
in cytosine nucleotides and
guanine nucleotides (CpG
islands). Epigenetic processes
can occur in response to nested
levels of exposures depicted at
the: individual, interpersonal,
community, and environmental
levels; each can influence
epigenetic modifications
independently or jointly.
Epigenetic responses may result
in more methylation that
tightens the chromatin bond
‘‘turning off’’ gene expression;
or, such processes may give rise
to demethylation, resulting in
loosely bound chromatin
‘‘turning on’’ gene expression.
Thus, detecting the amount of
methylation across the genome
or within a particular gene using
arrays or with sequencing
technologies can provide
evidence of epigenetic
responses to a set of exposures
(Color figure online)
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gested that health promotion interventions might best be
targeted to these ‘‘windows of responsivity’’ when exposures
may be particularly influential. Additionally, interventions
could be developed for those who share profiles of risk
exposure that occurred at periods of heightened responsivity
(Burdge & Lillycrop, 2010). In this way, understandings of
epigenetic mechanisms could offer new conceptualizations
for considering levels of influence, as well as selection and
timing of intervention approaches and outcomes.
Measuring epigenetic processes
Currently, epigenetic processes are measured by using a
variety of bioinformatics approaches to identify regions of
the genome with a high density of CpG islands (Bakulski &
Fallin, 2014; Shen & Waterland, 2007). Repetitive elements
(REs) such as CpG islands are over- or under-represented in
some areas of the genome. Typically, to measure epigenetic
modifications, these areas of the genome are searched for
regions characterized by: length (e.g., [500 base pairs),
number of GC pairs (over 55 %), the ratio of observed to
expected number of CpG repeats ([0.65) and the physical
distance between neighboring CpG islands (How Kit et al.,
2012; Shen & Waterland, 2007).
Areas known to be rich in concentration of REs (e.g.,
CpG islands) can be interrogated to indicate global
methylation, rapidly and relatively economically (How Kit
et al., 2012; Shen & Waterland, 2007). Other approaches
assess locus-specific methylation either for a candidate
gene or genome-wide. These methods begin by focusing on
specific genes identified from Genome Wide Association
Studies (GWAS) (Shen & Waterland, 2007). GWAS
studies are based on large numbers of cases and controls
and can be used to identify genes that lie in biologically
plausible pathways (e.g., inflammation, reward, metabo-
lism) for a specified behavioral or health outcome. Such
pathways also will inform the optimal timing of epigenetic
assessments. Notably, epigenetic assessments will require
study designs that include prospective and repeated mea-
sures designs in which individuals can serve as their own
controls; study designs that characterize health promotion
research (Bakulski & Fallin, 2014). Figure 1 provides a
conceptual overview of the links between exposome-level
factors and epigenetic mechanisms.
Summary
There are three broad conclusions to take away from this
technical overview of epigenetics. Firstly, epigenetic
mechanisms are influenced by a broad array of environ-
mental exposures, amenable to interventions, and reversible
(Godfrey et al., 2007; Loi et al., 2013). Second, there are
systematic methods for assessing epigenetic modifications to
the genome that are: increasingly affordable, and derivable
from biospecimens that are routinely and prospectively
collected in health promotion research (How Kit et al., 2012).
Lastly, pursuing these new and feasible directions for using
epigenetics in designing health promotion interventions and
research will have implications for study design and meth-
ods. For example, epigenetic plasticity means that changes
could be prompted by influences well beyond the scope of
the intervention. Thus, in the situations of limited experi-
mental control that characterize much of health promotion
contexts, consideration of study designs (e.g., within-sub-
jects designs) and comparison groups will be critical to
enhance scientific rigor. Moreover, recent research high-
lights the importance of the aging process on epigenetic
responses with some responses showing reverse associations
in older and younger age groups (Sierra et al., 2015). Such
effects could have design implications for intervention
research including the composition of study samples.
Potential applications of epigenetic concepts
in health promotion interventions
In the context of common complex disease, we assert that
epigenetic concepts could inform: (1) updates in health risk
information that could improve the motivational potency of
health communications, (2) the development of new
Table 1 Epigenetic discovery health promotion research innovation and translation
Epigenetic discovery Health promotion research innovation domains Example translational research questions
Individual variation in whether risk
exposures negatively influence gene
expression
Improving motivational potency of health
communications
Evaluating relative benefit of validating
beliefs about individual variability in
extent of harm produced by risk
behaviors on motivation
Intervention adherence can prompt
measurable gene expression
Intervention targeting and tailoring Comparative effectiveness of targeting
relapse prevention approach based on
gene expression profile following
intervention participation
New technology to measure epigenetic
processes (e.g., methylation) in saliva
and blood samples
Novel biomarkers of intervention impact Evaluate intervention adherence on gene
expression in randomized effectiveness
trials
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approaches to targeted and tailored interventions, and (3)
novel measures of intervention impact. In this section, we
expand on these points, offering several examples of how
epigenetics might inform the future of health promotion
research (Table 1).
Improving motivational potency of health
communications
Messaging is a key element of health promotion interven-
tions with the challenge being how to frame health risk
information in ways that motivate behavior change (Gal-
lagher & Updegraff, 2012). New understandings of epi-
genetic processes have been suggested for use to update
public health messages about health risks in ways that
might enhance both their credibility and persuasiveness
(Loi et al., 2013). For example, it is common to hear that
the public is confused and frustrated by contradictory
research findings related to risk exposures and health (e.g.,
alcohol intake is beneficial or harmful for some but not all
health outcomes). Moreover, public health recommenda-
tions to limit risk behaviors can be inconsistent with direct
experience—individuals are observed to stay healthy
despite engaging in risk behaviors such as cigarette
smoking or poor diet. This apparent lack of coherence in
explanations could lead the public to question the validity
of health recommendations (Cameron et al., 2012). There is
strong conceptual support that the public’s explanations (or
mental models) for individual differences in the health
effects of exposures (e.g., poor diet, cigarette smoking) can
influence their health behavior (Bostrom et al., 1992;
Cameron et al., 2012).
Additionally, when asked about the causes of common
health conditions, the public is likely to suggest health
behaviors and genetics as key factors. Environmental
exposures are less likely to be suggested, particularly by
majority populations and those not living in social disad-
vantage (Robert & Booske, 2011). Thus many of those
targeted by public health messages have limited imagina-
tions for the role of social environment on health (Robert &
Booske, 2011), and generally low literacy regarding how
genes and environment interact to influence health out-
comes (Condit & Shen, 2011). An example relevant to
epigenetics is that some genetic susceptibility factors only
become important in the presence of an environmental
exposure. Given the large and persistent health disparities
associated with social- and community-level exposures,
improved understanding of genome responsivity to the
environment could serve as a bridge linking social envi-
ronment exposures to health outcomes, decrease victim
blaming and galvanize public support for social environ-
mental solutions to public health problems (Thayer &
Kuzawa, 2011).
Health communications also could incorporate epige-
netic concepts to explain how exposures such as lifestyle
habits and the social environment can influence individuals
differently. For example, descriptions of how accumulating
exposures can turn genes on and off and influence health
outcomes could be used to illustrate the need to make
healthy lifestyle choices. Communications to increase
understanding of environmental responsivity and life stages
when risk might be heightened could be developed and
evaluated to increase the salience of adopting risk reduc-
tion during those developmental stages. Explanations that
validate beliefs about individual variability in response to
risky lifestyle behaviors could be compared to general
messages that recommend benefits for all, with regard to
their relative influence on risk perceptions, motivation to
reduce risk and behavior changes.
Among the many challenges these communication
approaches will face is how to leverage mental models of
individual variation in health outcomes while maintaining
motivation and personal efficacy that risk reduction is
needed and achievable. Communication strategies such as
metaphors concerning environmental responsivity could be
developed and rigorously evaluated for their effectiveness
in reducing target audiences’ likelihood of ascribing a
deterministic role to genetics (Cameron et al., 2012; Parrott
& Smith, 2014). These principles will undoubtedly include
conceptualizing ways that concepts relevant to epigenetics
(e.g., risk uncertainty) can be applied to increase the
motivational relevance and other constructs key to effec-
tive communications (Fischhoff & Davis, 2014). However
an important caveat is that such communications will not
have sufficient potency to promote behavior change (Hol-
lands et al., 2016). Thus, research, guided by social and
behavioral conceptual models, will be needed to evaluate
whether these communication updates add value to evi-
dence-based behavioral intervention approaches.
Intervention targeting and tailoring
Emerging understandings of variation in epigenetic
response also could be used to customize health promotion
interventions. Consider the work of Crujeiras et al. (2013)
that evaluated the association of epigenetic changes in
specific genes with appetite control among men who had
participated in a standard weight loss intervention (30 %
calorie restriction goal). Compared to non-regainers,
weight regainers (those who regained greater than 10 % of
weight lost) were more likely to have genes involved in
stimulating appetite turned on (i.e., lower total methylation
at loci) and to have genes associated with appetite sup-
pression turned off. These post-intervention epigenetic
responses to weight loss could be used to tailor or target
weight maintenance strategies to these groups. For exam-
J Behav Med (2017) 40:229–238 233
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ple, interventions could emphasize prolonged ongoing
support for those at highest risk and compare the value of
these approaches to standard weight maintenance approa-
ches.
Health promotion-related conceptual frameworks could
be helpful for specifying individual and group-level
exposures most germane for targeted or tailored interven-
tions. Antonucci et al. (2014), for example, conceptualize
accumulating exposures over a life span as a ‘‘convoy’’. In
considering the role of supportive others, they suggest that
individuals acquire a convoy of relationships that move
with them throughout the life course and change qualita-
tively over time. Linking this concept with epigenetic
mechanisms suggests that health risks, and the success of
health promotion interventions might be influenced by
shifts in qualities of this convoy of support at windows of
heightened responsivity. In considering which exposures
are critical the researcher could pose questions such as
what convoys of health behaviors, social support, or built
environment exposures were occurring at responsivity
milestones and have they changed detrimentally or bene-
ficially over the life course? As well, such an approach
could be used to identify those with exposure risk profiles
and tailor or target interventions accordingly.
Such interventions might target groups who share ‘‘ex-
posures’’ that occurred at important developmental junc-
tures of high epigenetic responsivity (Mitchell et al., 2013).
For example, intrauterine exposures have been shown to
prompt epigenetic effects on neuroendocrine response and
to be associated with increased likelihood of childhood and
adult-onset obesity (El Hajj et al., 2014). Thus, obesity
prevention interventions could be targeted to children born
to obese mothers. Individually tailored interventions also
could be evaluated as a motivational tool via personalized
feedback to mothers regarding their child’s prenatal
exposure. Integrating these approaches to leverage
mother’s motivation to protect their children may be a
particularly promising communication approach (Koehly
et al., 2015). Each of these approaches have support from
communication theory that they might increase the moti-
vational relevance of health behaviors and prompt more
thorough information processing than generic public health
messages (Griffin et al., 1999).
Novel measures of intervention impact
Understandings of epigenetics also could suggest new
biomarkers that are more sensitive to intervention adher-
ence and illuminate the processes through which inter-
ventions do or do not influence health outcomes. Too often
large well-designed intervention trials that are based on
strong conceptual models show null results, that is, no
benefit of the intervention over comparison groups. Often
intervention effectiveness is based on self-reported out-
comes. Many researchers have raised concerns that the
very act of completing repeated survey assessments could
prompt behavior change among participants in comparison
conditions or that responses reflect the heightened social
desirability of reporting behavior change (DeMaio, 1985).
Together, these factors may undermine the validity of self-
reports, even when using rigorous behavioral assessments,
and mask the benefits of health promotion interventions.
Health promotion research has a long tradition of using
biomarkers (e.g., saliva samples) to validate self-reported
behavior change where possible and to minimize related
threats to validity when evaluating intervention effective-
ness. Similarly epigenetic methylation processes could be
assessed to indicate whether self-reported intervention
adherence is concordant with physiological processes that
might improve intervention adherence (e.g., release of
dopamine associated with improved mood) or benefits of
sustained behavior change (e.g., changes in gene expres-
sion associated with inflammation processes). These new
approaches could give evidence of whether improvements
in self-reported initiation and maintenance of behavior
change deemed statistically insignificant are in fact con-
cordant with physiological responses that suggest health
benefit of intervention participation. It is possible that
interventions shown to produce small improvements in
health habits relative to a comparison group bring physi-
ological benefits that are currently not being measured.
Bryan and colleagues are among the few research teams
that evaluated the effect of participating in health promo-
tion interventions and its association with epigenetic pro-
cesses (Bryan et al., 2013). Their preliminary findings with
64 participants who participated in a 12-month exercise
intervention gives insight into the link between physical
activity and breast cancer. Self-reported physical activity
based on the frequently used physical activity record
(PAR) was associated with epigenetic modifications
involved in turning off genes that prevent the cell prolif-
eration that gives rise to malignant breast tumors. These
epigenetic changes could be added as indicators of inter-
vention benefit. Similarly, Ronn and colleagues assessed
genome wide methylation in the adipose tissue of sedentary
men before and after their participation in a 6-month
exercise intervention (Ronn et al., 2013). The investigators
analyzed abdominal adipose biopsies from men before and
48 h after their last exercise session. Results indicated a
comprehensive increase in methylation (turning genes off)
in all regions suggesting a more metabolically active adi-
pose tissue after intervention participation.
In each of these instances, the health promotion
researcher hypothesizes and tests, for example, whether
adherence to a behavior change intervention is associated
with methylation (appropriately turning genes off or on)
234 J Behav Med (2017) 40:229–238
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that may be biologically beneficial for the health outcome
of interest or influenced by intervention participation.
Additionally, these approaches could enable evaluation of
whether the intervention group or some subgroup of indi-
viduals based on intervention adherence level or convoy
characteristics (e.g., life course social support or stress)
show patterns of methylation consistent with a conceptual
model or hypothesis. Thus, methylation patterns offer a
measure of epigenetic modifications that may be more
sensitive to intervention effectiveness.
Epigenetic informed health promotion research:
‘‘How To’’ steps
Incorporating epigenetic-related biomarkers into health
promotion interventions has been done relatively infre-
quently. However, those who have succeeded used a sys-
tematic approach that we have summarized in a three-step
process. The process begins with development of a con-
ceptual model that emphasizes the defined ‘‘exposome’’
most germane to the health outcome and target population
(e.g., levels of influence as shown in Fig. 1). In subsequent
steps, the model is used to guide selection of appropriate
intervention components, and the genes and biological
pathways that would be expected to be influenced by the
intervention.
Step 1: Settling on a conceptual model
Many have suggested that epigenetic processes can offer
conceptual pathways to link levels of social and interper-
sonal influence on health outcomes (Burdge & Lillycrop,
2010; Loi et al., 2013; Thayer & Kuzawa, 2011). Though
rarely operationalized beyond two levels of influence, the
social-ecological framework now has a ubiquitous presence
in health promotion research (Golden & Earp, 2012). Such
multi-level conceptual models often are depicted as con-
centric circles of influence that are nested one within the
other. These models favor comprehensive enumeration of
all possible social and behavioral constructs of the ‘‘ex-
posome’’ (Glass & McAtee, 2006). However, missing or
only vaguely conceptualized in these complex depictions
are the proposed mechanisms that connect levels of influ-
ence to health outcomes as depicted in Fig. 1.
An example is that most health promotion interventions
achieve incomplete adherence. Poor adherence may be
attributed to built environment factors (macro level),
household factors (interpersonal level) and mood state
(individual level). Thus, a focused social ecological model
might be constructed using epigenetic mechanisms to link
levels of influence to intervention adherence. For example,
the conceptual model would consider epigenetic mecha-
nisms (e.g., reward pathways) that may be prompted by or
encourage intervention adherence within a specific context.
In turn, inclusion of epigenetic assessment could illuminate
whether, the intervention group or some subgroup of par-
ticipants show patterns of methylation that vary in accor-
dance with a multi-level conceptual model or hypothesis.
Additionally, the model could posit potential effect mod-
erators such as exposure convoys (e.g., changes in life
course social support or stress) or adherence level.
Imagining potential methylation patterns requires some
understanding of the families of genes that could plausibly
be influenced by the intervention. This is important because
the aim is not to evaluate all pathways but to parsimo-
niously consider those most plausible and specific to the
influence levels (i.e., intrapersonal, interpersonal, social)
under consideration. Lastly, a conceptual model can guide
decisions about the appropriate comparison groups against
which the influence of the intervention on epigenetic pro-
cesses would be evaluated.
For example, Bryan et al. (2011) proposed a model in
which cognitive and physiological pathways were sug-
gested to enhance or diminish motivation to exercise and in
turn, adherence to recommended activity level. In their
model, genetic factors were hypothesized to influence
mood benefit from exercise and perceptions of exertion. In
turn, these factors were posited to jointly influence adher-
ence to physical activity requirements. Lastly, adherence
was thought to influence gene expression via epigenetic
influences.
One limitation of Bryan et al. (2011) model is that these
mechanisms were delineated only at a single level of
influence (i.e., intrapersonal) without considering inter-
personal or other environmental influences. One can
imagine broadening this conceptualization to include co-
exercisers, for example, who encourage (or ignore) each
other during the exercise session as well as the availability
of environmental opportunities to be physically active (e.g.,
access to recreational facilities). This broader conceptual-
ization admittedly would be more complex. However, a
conceptual framework could be constructed to narrow in on
a socio-ecological ‘‘exposome’’ hypothesized to be most
relevant for promoting physical activity that in turn, could
guide hypothesis development regarding epigenetic mech-
anisms to consider.
Step 2: Use the conceptual model to characterize
appropriate intervention targets
Once the conceptual framework has been determined, the
next step is to specify the intervention elements where
influence could be identified via epigenetic mechanisms.
Building on Bryan et al. (2011) example introduced above,
the literature could support involvement at the interper-
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sonal level of a co-exerciser as a means to improve
adherence. The researcher would then consider through
which mechanisms participants’ responses to this mutual
support might influence activity adherence. Would it
influence stress, making it easier or harder to adhere to
activity recommendations? How might an exposure convoy
(e.g., individual level or group shared exposures) influence
the extent of these influences on activity? In turn, where
would the effects of considering these exposures be
expected to show up in downstream epigenetic processes
associated with stress response? In this exercise, the
researcher also must consider which intervention strategies
to use to optimally influence adherence. Lastly, the choice
of epigenetic assessments would be linked directly to the
intervention approaches selected.
For example, Crujeiras et al. (2013) hypothesized that
because energy balance is influenced by two competing
mechanisms. Ghrelin secreted by the stomach that activates
neuropeptides through epigenetic processes to stimulate
appetite, and leptin secreted by fat cells suppresses the
appetite via other epigenetic processes. These mechanisms
suggest a testable hypothesis that an intervention tailored to
the appetite-related methylation pathway might improve
long-term maintenance of weight loss. Moreover, this
approach suggested a new biomarker of impact, that is,
could the maintenance strategy be linked directly to
specific methylation patterns? As mentioned previously,
those who regained more of their weight loss had methy-
lation patterns indicating that genes associated with appe-
tite control were turned off. These patterns were not
present among those who maintained weight loss. Again,
missing from this study was consideration of levels of
influence beyond the individual. This could be accom-
plished by considering which higher levels of influence
might also be influencing these methylation patterns.
Step 3: Specify appropriate biomarker indicators
to use as outcomes in evaluating the impact
of the intervention
In this step, the researcher decides on the optimal epige-
netic assessment and timing of measures. These consider-
ations would logically build upon the prior steps in
suggesting where and when epigenetic changes might
occur if prescribed adherence levels were attained.
A prospective study conducted by Bryan et al. (2013)
offers an excellent example of this process. The study
evaluated whether self-reported increases in physical
activity induced epigenetic patterns associated with
reduced risk of breast cancer. To arrive at biomarkers, the
authors reviewed work based on tumor cells of cancer
patients versus controls to identify biologically plausible
pathways through which increased exercise might reduce
cancer risk. The authors settled on a gene-specific
expression processes associated with cell death, ‘‘apopto-
sis-associated speck-like protein containing a caspase
recruitment domain’’ or ASC. Epigenetic processes in
which the ASC gene gets turned off, are associated with
lower levels of inflammation. Inflammation in turn, has
been consistently linked to cancer and other chronic dis-
eases (e.g., obesity and Type 2 diabetes).
The researchers selected a priori the CpG islands linked
to breast cancer acquisition and progression, and then
developed a ‘‘composite measure’’ of these sites. Several
sources were used to identify the epigenetic markers that
comprised the composite measures. For example, genes
and variants gleaned from a literature review included
those studied among breast cancer patients taken from
tumor cells and those suggested as possible preclinical
markers for breast cancer. Other potential CpG sites were
identified through an online annotation file available from
Illumina; additional genes were identified that had been
suggested to play a functional role in breast cancer devel-
opment. In all, the researchers settled on 21 genes and 45
markers to analyze for their association with improvements
in physical activity and hypothesized that DNA methyla-
tion across these sites would be negatively associated with
self-reported physical activity levels (based on the PAR)
and cardiovascular fitness (based on VO2 max). Saliva
samples were collected prospectively at three-month
intervals up to a year after intervention participation. DNA
extracted from the saliva was analyzed via a commercially
available Illumina platform that enabled methylation pat-
terns to be evaluated (Bryan et al., 2013).
Conclusions
Whether epigenetics can be used into improve health pro-
motion interventions and research in the ways we have
suggested raises numerous scientific questions worth
exploring. A compelling advantage of pursuing this trans-
lational research is that emerging discovery in epigenetics
may illuminate modifiable mechanisms that link different
levels of influence on health and intervention benefits
overlooked by current measures. Tractable research ques-
tions and related development of testable multi-level con-
ceptual frameworks could move the field beyond the
predominant focus of intervention research targeting a
single level of influence. Accordingly, integrating epige-
netics into health promotion research will call for inter-
vention and methodological accommodations. Health
promotion researchers can take the lead in keeping such
research in the forefront of precision medicine discussions
that will be increasing in the decade ahead. Indeed, the
potential for launching a new generation of conceptual
236 J Behav Med (2017) 40:229–238
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models, interventions and related methods informed by
genomic discoveries should embolden us to gain the skills
needed to engage in and advocate for this arena of trans-
lational research.
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